GST-P1 as a histological biomarker of synovial sarcoma revealed by proteomics

Proteomics - Clinical Applications

Volumn 3, Issue 5, 2009, Pages 623-634

  Suehara, Yoshiyuki ^a,b,c   Kikuta, Kazutaka ^a,c,d   Nakayama, Robert ^a,d   Tochigi, Naobumi ^a   Seki, Kunihiko ^a,e   Ichikawa, Hitoshi ^a   Fujii, Kiyonaga ^a,f   Hasegawa, Tadashi ^a,g   Shimoda, Tadakazu ^a   Kurosawa, Hisashi ^b   Chuman, Hirokazu ^c   Beppu, Yasuo ^c   Kawai, Akira ^c   Hirohashi, Setsuo ^a   Kondo, Tadashi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d KEIO UNIVERSITY   (Japan)

^e JR Tokyo General Hospital   (Japan)

^f HOKKAIDO UNIVERSITY   (Japan)

^g SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

2 D DIGE; GST P1; Proteomics; Synovial sarcoma

Indexed keywords

GLUTATHIONE TRANSFERASE P1; TUMOR MARKER;

ADOLESCENT; ADULT; ARTICLE; CANCER CLASSIFICATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DISEASE MARKER; FEMALE; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ION TRANSPORT; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEOMICS; SCHOOL CHILD; SYNOVIAL SARCOMA; TRANSLATION REGULATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 67649452101     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800211     Document Type: Article

References (61)

1. Fletcher, C., Unni, K., Mertens, F., Pathology and Genetics Tumours of Soft Tissue and Bone. IARCP Press, Lyon, France 2002, pp. 200-204.
2. Lewis, J. J., Antonescu, C. R., Leung, D. H., Blumberg, D. et al., Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J. Clin. Oncol. 2000, 18, 2087-2094.
3. Spillane, A. J., A'Hern, R., Judson, I. R., Fisher, C., Thomas, J. M., Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J. Clin. Oncol. 2000 18 3794-3803.
4. Trassard, M., Le Doussal, V., Hacene, K., Terrier, P et al., Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J. Clin. Oncol. 2001, 19, 525-534.
5. Clark, J., Rocques, P. J., Crew, A. J., Gill, S. et al., Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat. Genet. 1994, 7, 502-508.
6. Skytting, B., Nilsson, G., Brodin, B., Xie, Y. et al., A novel fusion gene, SYT-SSX4, in synovial sarcoma. J. Natl. Cancer Inst. 1999, 91, 974-975.
7. Nagai, M., Tanaka, S., Tsuda, M., Endo, S. et al., Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha. Proc. Natl. Acad. Sci. USA 2001, 98, 3843-3848.
8. dos Santos, N. R., de Bruijn, D. R., van Kessel, A. G., Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer 2001, 30, 1-14.
9. Kawai, A., Woodruff, J., Healey, J. H., Brennan, M. F. et al., SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N. Engl. J. Med. 1998, 338, 153-160.
10. Antonescu, C. R., Kawai, A., Leung, D. H., Lonardo, F. et al., Strong association of SYT-SSX fusion type andmorphologic epithelial differentiation in synovial sarcoma. Diagn. Mol. Pathol. 2000, 9, 1-8.
11. Ladanyi, M., Correlates of SYT-SSX fusion type in synovial sarcoma: getting more complex but also more interesting? J. Clin. Oncol. 2005, 23, 3638-3639; author reply 3639-3640.
12. Guillou, L., Benhattar, J., Bonichon, F., Gallagher, G. et al., Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J. Clin. Oncol. 2004, 22, 4040-4050.
13. Takenaka, S., Ueda, T., Naka, N., Araki, N. et al., Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan. Oncol. Rep. 2008, 19, 467-476.
14. Allander, S. V., Illei, P. B., Chen, Y., Antonescu, C. R. et al., Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am. J. Pathol. 2002, 161, 1587-1595.
15. Nagayama, S., Katagiri, T., Tsunoda, T., Hosaka, T. et al., Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray. Cancer Res. 2002, 62, 5859-5866.
16. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J. et al., Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-577.
17. Suehara, Y., Kondo, T., Fujii, K., Hasegawa, T. et al., Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas. Proteomics 2006, 6, 4402-4409.
18. Suehara, Y., Kondo, T., Seki, K., Shibata, T. et al., Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics. Clin. Cancer Res. 2008, 14, 1707-1717.
19. Chen, G., Gharib, T. G., Wang, H., Huang, C. C. et al., Protein profiles associated with survival in lung adenocarcinoma. Proc. Natl. Acad. Sci. USA 2003, 100, 13537-13542.
20. Okano, T., Kondo, T., Fujii, K., Nishimura, T. et al., Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma. Clin. Cancer Res. 2007, 13, 799-805.
21. Shimizu, K., Toriyama, F., Yoshida, H., The expression of placental-type glutathione S-transferase (GST-pi) in human cutaneous squamous cell carcinoma and normal human skin. Virchows Arch. 1995 425, 589-592.
22. Konohana, A., Konohana, I., Schroeder, W. T., O'Brien, W. R. et al., Placental glutathione-S-transferase-pi mRNA is abundantly expressed in human skin. J. Invest. Dermatol. 1990, 95, 119-126.
23. Moscow, J. A., Townsend, A. J., Cowan, K. H., Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins. Mol. Pharmacol. 1989, 36, 22-28.
24. Manoharan, T. H., Puchalski, R. B., Burgess, J. A., Pickett, C. B., Fahl, W. E., Promoter-glutathione S-transferase Ya cDNA hybrid genes. Expression and conferred resistance to an alkylating molecule in mammalian cells. J. Biol. Chem. 1987 262, 3739-3745.
25. Morrow, C. S., Cowan, K. H., Goldsmith, M. E., Structure of the human genomic glutathione S-transferase-pi gene. Gene 1989 75, 3-11.
26. Teicher, B. A., Holden, S. A., Kelley, M. J., Shea, T. C. et al., Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res. 1987 47, 388-393.
27. Shea, T. C., Kelley, S. L., Henner, W. D., Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines. Cancer Res. 1988, 48, 527-533.
28. Allan, J. M., Wild, C. P., Rollinson, S., Willett, E. V. et al., Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Proc. Natl. Acad. Sci. USA 2001, 98, 11592-11597.
29. Arai, T., Miyoshi, Y., Kim, S. J., Taguchi, T. et al., Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers. Breast Cancer Res. Treat. 2006 100, 169-176.
30. Kano, T., Sakai, M., Muramatsu, M., Structure and expression of a human class pi glutathione S-transferase messenger RNA. Cancer Res. 1987 47, 5626-5630.
31. Moscow, J. A., Townsend, A. J., Goldsmith, M. E., Whang-Peng, J. et al., Isolation of the human anionic glutathione S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer. Proc. Natl. Acad. Sci. USA 1988, 85, 6518-6522.
32. Kodate, C., Fukushi, A., Narita, T., Kudo, H. et al., Human placental form of glutathione S-transferase (GST-pi) as a new immunohistochemical marker for human colonic carcinoma. Jpn. J. Cancer Res. 1986, 77, 226-229.
33. Li, Y. C., Seyama, T., Godwin, A. K., Winokur, T. S. et al., MTrasT24, a metallothionein-ras fusion gene, modulates expression in cultured rat liver cells of two genes associated with in vivo liver cancer. Proc. Natl. Acad. Sci. USA 1988, 85, 344-348.
34. Buller, A. L., Clapper, M. L., Tew, K. D., Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines. Mol. Pharmacol. 1987, 31, 575-578.
35. Kondo, T., Hirohashi, S., Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat. Protoc. 2006, 1, 2940-2956.
36. Klose, J., Nock, C., Herrmann, M., Stuhler, K. et al., Genetic analysis of the mouse brain proteome. Nat. Genet. 2002, 30, 385-393.
37. Xie, Y., Tornkvist, M., Aalto, Y., Nilsson, G. et al., Gene expression profile by blocking the SYT-SSX fusion gene in synovial sarcoma cells. Identification of XRCC4 as a putative SYT-SSX target gene. Oncogene 2003, 22, 7628-7631.
38. Miettinen, M., Keratin subsets in spindle cell sarcomas. Keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins. Am. J. Pathol. 1991, 138, 505-513.
39. Miettinen, M., Limon, J., Niezabitowski, A., Lasota, J., Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas. Virchows Arch. 2000, 437, 275-283.
40. Wanibuchi, H., Wei, M., Karim, M. R., Morimura, K. et al., Existence of no hepatocarcinogenic effect levels of 2-amino-3, 8-dimethylimidazo[4, 5-f]quinoxaline with or without coadministration with ethanol. Toxicol. Pathol. 2006, 34, 232-236.
41. Sato, K., Glutathione transferases as markers of preneoplasia and neoplasia. Adv. Cancer Res. 1989, 52, 205-255.
42. Moscow, J. A., Fairchild, C. R., Madden, M. J., Ransom, D. T. et al., Expression of anionic glutathione-S-transferase and Pglycoprotein genes in human tissues and tumors. Cancer Res. 1989, 49, 1422-1428.
43. Satoh, K., Kitahara, A., Soma, Y., Inaba, Y. et al., Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc. Natl. Acad. Sci. USA 1985, 82, 3964-3968.
44. Blencowe, B. J., Alternative splicing: new insights from global analyses. Cell 2006, 126, 37-47.
45. Chignard, N., Shang, S., Wang, H., Marrero, J. et al., Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera. Gastroenterology 2006, 130, 2010-2022.
46. Santos, M., Ballestin, C., Garcia-Martin, R., Jorcano, J. L., Delays in malignant tumor development in transgenic mice by forced epidermal keratin 10 expression in mouse skin carcinomas. Mol. Carcinog. 1997, 20, 3-9.
47. Ivanyi, D., Ansink, A., Mooi, W. J., de Kraker, N.W., Heintz, A. P., Absence of differentiation-related expression of keratin 10 in early stages of vulvar squamous carcinoma. Differentiation 1989, 42, 124-129.
48. Ivanyi, D., Ansink, A., Groeneveld, E., Hageman, P. C. et al., New monoclonal antibodies recognizing epidermal differentiation-associated keratins in formalin-fixed, paraffin-embedded tissue. Keratin 10 expression in carcinoma of the vulva. J. Pathol. 1989, 159, 7-12.
49. Darmon, M. Y., Semat, A., Darmon, M. C., Vasseur, M., Sequence of a cDNA encoding human keratin No 10 selected according to structural homologies of keratins and their tissue-specific expression. Mol. Biol. Rep. 1987, 12, 277-283.
50. Melloni, R. H., Jr., Tokito, M. K., Holzbaur, E. L., Expression of the p150Glued component of the dynactin complex in developing and adult rat brain. J. Comp. Neurol. 1995, 357, 15-24.
51. Murphey, R. K., Caruccio, P. C., Getzinger, M., Westgate, P. J., Phillis, R. W., Dynein-dynactin function and sensory axon growth during Drosophila metamorphosis: A role for retrograde motors. Dev. Biol. 1999, 209, 86-97.
52. Eaton, B. A., Fetter, R. D., Davis, G.W., Dynactin is necessary for synapse stabilization. Neuron 2002, 34, 729-741.
53. Levy, J. R., Sumner, C. J., Caviston, J. P., Tokito, M. K. et al., A motor neuron disease-associated mutation in p150Glued perturbs dynactin function and induces protein aggregation. J. Cell. Biol. 2006, 172, 733-745.
54. Mikenberg, I., Widera, D., Kaus, A., Kaltschmidt, B., Kaltschmidt, C., Transcription factor NF-kappaB is transported to the nucleus via cytoplasmic dynein/dynactin motor complex in hippocampal neurons. PLoS ONE 2007, 2, e589.
55. Ateh, D. D., Hussain, I. K., Mustafa, A. H., Price, K. M. et al., Dynein-dynactin complex subunits are differentially localized in brain and spinal cord, with selective involvement in pathological features of neurodegenerative disease. Neuropathol. Appl. Neurobiol. 2008, 34, 88-94.
56. Sifaki, M., Assouti, M., Nikitovic, D., Krasagakis, K. et al., Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes. IUBMB Life 2006, 58, 606-610.
57. Matheson, S., Larjava, H., Hakkinen, L., Distinctive localization and function for lumican, fibromodulin and decorin to regulate collagen fibril organization in periodontal tissues. J. Periodontal Res. 2005, 40, 312-324.
58. Chakravarti, S., Paul, J., Roberts, L., Chervoneva, I. et al., Ocular and scleral alterations in gene-targeted lumican-fibromodulin double-null mice. Invest. Ophthalmol. Vis. Sci. 2003, 44, 2422-2432.
59. Ezura, Y., Chakravarti, S., Oldberg, A., Chervoneva, I., Birk, D. E., Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J. Cell. Biol. 2000, 151, 779-788.
60. Sztrolovics, R., Alini, M., Mort, J. S., Roughley, P. J., Age-related changes in fibromodulin and lumican in human intervertebral discs. Spine 1999, 24, 1765-1771.
61. Chasserot-Golaz, S., Vitale, N., Umbrecht-Jenck, E., Knight, D. et al., Annexin 2 promotes the formation of lipid microdomains required for calcium-regulated exocytosis of dense-core vesicles. Mol. Biol. Cell 2005, 16, 1108-1119.